Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Brookfield Renewable Partners LP
BEP.UN
5
The Toronto-Dominion Bank
TD
(Q1)Jan 31, 2025 | (FY)Oct 31, 2024 | (Q4)Oct 31, 2024 | (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q3)Jul 31, 2023 | (Q2)Apr 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -22.42%-400.06K | 11.35%-1.06M | 32.87%-130.85K | -67.87%-391.19K | 45.09%-208.59K | 15.12%-326.79K | 35.48%-1.19M | 5.49%-194.91K | 63.07%-233.02K | 20.77%-379.84K |
Net income from continuing operations | 25.42%-306.99K | -15.72%-1.84M | -18.85%-453.23K | -255.67%-608.4K | 34.79%-367.05K | 13.36%-411.61K | 37.78%-1.59M | 10.94%-381.33K | 74.17%-171.06K | 38.65%-562.84K |
Operating gains losses | ---- | ---43.96K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization | -19.84%63.91K | -7.38%302.63K | -15.63%68.76K | -12.57%74.38K | -1.68%79.75K | 0.85%79.73K | 29.61%326.75K | 2.48%81.51K | 26.61%85.07K | 33.76%81.12K |
Asset impairment expenditure | --94.18K | --320.78K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Remuneration paid in stock | --0 | 115.26%303.21K | --0 | 1,028.22%213.57K | --0 | --89.64K | -63.94%140.86K | --0 | -39.24%18.93K | --121.93K |
Other non cashItems | -153.95%-8.01K | 75.02%-48.94K | 62.24%-91.69K | -12.80%13.65K | -7.44%14.24K | -6.34%14.85K | -468.97%-195.9K | -190.15%-242.79K | -3.90%15.65K | -5.87%15.39K |
Change In working capital | -144.62%-243.15K | -140.40%-50.83K | -87.17%44.6K | 49.07%-92.49K | 372.23%96.46K | -1,956.21%-99.4K | 27.90%125.82K | 53.77%347.71K | -117.56%-181.62K | -3,615.38%-35.44K |
-Change in receivables | -4,796.83%-8.88K | -116.97%-3.76K | 1,887.52%10.89K | -99.46%647 | 84.87%-15.48K | -96.55%189 | 207.62%22.16K | -100.89%-609 | 1,118.43%119.58K | -140.30%-102.29K |
-Change in prepaid assets | ---21K | -108.84%-1.57K | -72.68%674 | 1,740.77%36.21K | -634.69%-38.46K | --0 | -87.99%17.79K | -83.25%2.47K | 114.27%1.97K | -95.05%7.19K |
-Change in payables and accrued expense | -665.77%-188.27K | -58.57%4.51K | -97.03%8.04K | 57.33%-129.35K | 152.07%150.4K | -49.20%-24.59K | -61.27%10.87K | 18.71%270.85K | -281.31%-303.16K | 158.67%59.67K |
-Change in other working capital | 66.67%-25K | -166.67%-50K | --25K | --0 | --0 | ---75K | --75K | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -22.42%-400.06K | 11.35%-1.06M | 32.87%-130.85K | -67.87%-391.19K | 45.09%-208.59K | 15.12%-326.79K | 35.48%-1.19M | 5.49%-194.91K | 63.07%-233.02K | 20.77%-379.84K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -1,861.86%-115K | -195.62%-256.37K | 277.09%18.34K | -1,312.67%-108.35K | -216.31%-160.49K | 67.36%-5.86K | 87.49%-86.72K | 91.96%-10.36K | 27.68%-7.67K | 80.76%-50.74K |
Net PPE purchase and sale | -3,178.62%-181.7K | -451.71%-414.57K | -2,423.48%-153.6K | -1,891.52%-132.46K | -165.49%-122.96K | 65.55%-5.54K | 88.27%-75.14K | 93.59%-6.09K | 37.28%-6.65K | 82.44%-46.32K |
Net intangibles purchas and sale | --0 | --0 | 422.07%13.75K | 2,465.46%24.1K | -748.33%-37.53K | 82.89%-320 | 78.08%-11.58K | 87.41%-4.27K | ---1.02K | ---4.42K |
Net other investing changes | --66.7K | --158.2K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -1,861.86%-115K | -195.62%-256.37K | 277.09%18.34K | -1,312.67%-108.35K | -216.31%-160.49K | 67.36%-5.86K | 87.49%-86.72K | 91.96%-10.36K | 27.68%-7.67K | 80.76%-50.74K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -48.72%436.48K | 10.78%1.42M | 38.50%245.14K | -55.68%85.4K | -48.38%236.42K | 88.16%851.11K | -48.22%1.28M | 64.96%176.99K | 501.07%192.72K | -70.65%458.05K |
Net issuance payments of debt | -5.61%-83.57K | -5.27%-93.09K | -94.23%21.42K | -57.66%-41.24K | 100.20%5.86K | 81.85%-79.13K | -129.32%-88.44K | 204.17%370.87K | 31.25%-26.16K | 101.07%2.93K |
Net common stock issuance | -45.46%565K | 31.29%1.62M | --250.03K | 30.32%95.13K | -47.64%242.95K | 47.99%1.04M | -50.52%1.24M | --0 | --73K | -74.22%464K |
Proceeds from stock option exercised by employees | ---- | -83.16%37.5K | --0 | -74.60%37.5K | ---- | ---- | -14.11%222.63K | ---192.3K | --147.63K | --0 |
Net other financing activities | 57.46%-44.95K | -65.01%-150.34K | -1,570.90%-26.3K | -242.02%-5.98K | -39.48%-12.39K | -33.92%-105.67K | 63.35%-91.11K | 89.24%-1.57K | 82.51%-1.75K | 95.54%-8.88K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -48.72%436.48K | 10.78%1.42M | 38.50%245.14K | -55.68%85.4K | -48.38%236.42K | 88.16%851.11K | -48.22%1.28M | 64.96%176.99K | 501.07%192.72K | -70.65%458.05K |
Net cash flow | ||||||||||
Beginning cash position | 143.49%176.99K | 0.84%72.69K | -56.07%44.36K | 207.83%458.49K | 386.64%591.15K | 0.84%72.69K | -49.23%72.09K | -66.33%100.96K | -84.95%148.94K | -29.32%121.47K |
Current changes in cash | -115.16%-78.58K | 17,225.58%104.3K | 569.11%132.64K | -763.19%-414.13K | -582.97%-132.66K | 949.80%518.46K | 100.86%602 | 87.59%-28.27K | 93.04%-47.98K | -96.64%27.47K |
End cash Position | -83.35%98.41K | 143.49%176.99K | 143.49%176.99K | -56.07%44.36K | 207.83%458.49K | 386.64%591.15K | 0.84%72.69K | 0.84%72.69K | -66.33%100.96K | -84.95%148.94K |
Free cash from | -74.89%-581.76K | -20.98%-1.55M | -68.90%-346.7K | -107.54%-499.54K | 14.28%-369.08K | 17.44%-332.65K | 49.67%-1.28M | 38.74%-205.27K | 62.49%-240.69K | 42.06%-430.58K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.